Maze Therapeutics Cash Flow Statement (2024-2025) | MAZE

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -27.73M139.06M-24.75M-29.58M-32.79M-33.68M-30.09M-34.57M
Depreciation and Depletion (Quarter) 0.95M0.85M0.79M0.70M0.68M0.65M0.57M0.50M
Share-based Compensation (Quarter) 2.31M2.14M2.34M2.85M3.23M3.24M3.86M6.07M
Gains from Sales and Divestitures (Quarter) 1.11M1.11M
Gains from Investment Securities (Quarter) 5.28M5.35M5.75M
Non-cash Items (Quarter) 30.00M26.80M24.80M1.70M2.72M
Cash from Operations (Quarter) -23.44M145.05M-23.20M-22.45M-29.52M-30.05M-24.64M-27.73M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.23M
Depreciation & Amortization (CF) (Quarter) 0.95M0.85M0.79M0.70M0.68M0.65M0.57M0.50M
Change in Working Capital
Change in Account Payables (Quarter) -0.24M0.39M-1.17M0.82M0.58M1.27M-0.75M-1.12M
Change in Accured Expenses (Quarter) -0.13M3.80M-1.70M1.84M-1.06M0.11M2.48M1.96M
Investing Activities
Capital Expenditures (Quarter) 0.05M0.39M-0.23M0.94M0.05M0.64M-0.66M0.76M
Cash from Investing Activities (Quarter) -0.28M-0.16M-0.10M-0.60M-0.30M-0.39M-66.88M-103.39M
Financing Activities
Change in Capital Stock
Shares Issued (Quarter) 0.36M0.08M0.23M0.06M0.13M2.01M125.62M
Misc.
Cash from Financing Activities (Quarter) 24.58M0.15M-2.15M70.26M127.38M0.61M143.76M3.59M
Change in Cash (Quarter) 0.86M145.04M-25.46M47.20M97.56M-29.83M52.23M-127.53M
Free Cash Flow (Quarter) -23.48M144.66M-22.97M-23.39M-29.56M-30.70M-23.98M-28.49M
Net Cash Flow (Quarter) 0.86M145.04M-25.46M47.20M97.56M-29.83M52.23M-127.53M